United States · FDA National Drug Code directory
Diltiazem Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-729_063fdd2a-2532-45c6-8bb1-318064ff77bf
- Product NDC
- 46708-729
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Diltiazem Hydrochloride
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241114
- Source listing expiry
- 20261231
Source-listed ingredients
- DILTIAZEM HYDROCHLORIDE — 360 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-729-30) · 46708-729-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-729-90) · 46708-729-90
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (46708-729-91) · 46708-729-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →